Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorybpc-157unapproved drugsrfk jrpeptides

Unapproved 'Wolverine' peptide use surges amid RFK Jr. backing

Consumers are turning to the unapproved injury-recovery peptide despite the absence of regulatory clearance.

DO
By Daniel Okafor · Regulatory Correspondent
Sep 15 21:45 ETSource: Health and Me

The wire

  1. 01Reports describe rising use of an unapproved 'Wolverine' recovery peptide promoted with backing from RFK Jr.
  2. 02Growing consumer demand for unapproved peptides raises safety and oversight questions.
  3. 03Regulators have not announced action, and evidence of efficacy remains unestablished.

From the source

RFK Jr-Backed ‘Wolverine’ Peptide Use Surges: Why Are People Taking An Unapproved Drug For Injury Recovery?

Read at news.google.com